Singapore markets close in 3 hours 38 minutes
Straits Times Index
3,059.55-11.68(-0.38%)Nikkei
30,500.05+176.75(+0.58%)Hang Seng
23,999.82-920.94(-3.70%)FTSE 100
6,963.64-63.84(-0.91%)BTC-USD
45,787.21-2,153.23(-4.49%)CMC Crypto 200
1,145.42-80.11(-6.54%)
Cyclerion Therapeutics, Inc. (CYCN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1200+0.0200 (+0.65%)
At close: 4:00PM EDT
| Previous close | 3.1000 |
| Open | 3.1500 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 1200 |
| Day's range | 3.0700 - 3.4664 |
| 52-week range | 2.0800 - 8.3400 |
| Volume | 932,264 |
| Avg. volume | 602,630 |
| Market cap | 135.023M |
| Beta (5Y monthly) | 1.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.9900 |
| Earnings date | 25 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Why Cyclerion Therapeutics Is Crashing Today
Shares of clinical-stage biotech Cyclerion Therapeutics (NASDAQ: CYCN) are down by an eye-popping 48% as of noon EDT Wednesday. The small-cap biotech's stock is crashing in response to a negative midstage trial result for its sickle cell disease candidate olinciguat. Sickle cell disease is a rare blood disorder with limited treatment options.
© 2021 Verizon Media. All rights reserved.
